Vimarsana
Biggest News Aggregation in the World

Page 6 - Michael Downes News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michael Downes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michael Downes Today - Breaking & Trending Today

Nantahala Capital Management LLC Has $24.83 Million Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Vimarsana News

Nantahala Capital Management LLC Has $24.83 Million Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)

Nantahala Capital Management LLC reduced its holdings in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Rating) by 30.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 975,705 shares of the company’s stock after selling 429,723 shares during the period. […]

Syndax Pharmaceuticals (NASDAQ:SNDX) Trading 8.6% Higher - Vimarsana News

Syndax Pharmaceuticals (NASDAQ:SNDX) Trading 8.6% Higher

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Rating)’s stock price traded up 8.6% during trading on Tuesday . The company traded as high as $22.67 and last traded at $22.53. 576,831 shares traded hands during trading, a decline of 32% from the average session volume of 842,487 shares. The stock had previously closed at $20.74. Analyst […]

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Director Sells $1,119,468.90 in Stock - Vimarsana News

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Director Sells $1,119,468.90 in Stock

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Rating) Director Briggs Morrison sold 52,855 shares of the stock in a transaction on Friday, June 9th. The stock was sold at an average price of $21.18, for a total value of $1,119,468.90. Following the completion of the transaction, the director now directly owns 17,836 shares of the company’s […]

683 Capital Management LLC Has $14.51 Million Stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Vimarsana News

683 Capital Management LLC Has $14.51 Million Stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)

683 Capital Management LLC reduced its stake in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Rating) by 49.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 570,000 shares of the company’s stock after selling 560,000 shares during the period. Syndax […]

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives $33.86 Average Price Target from Brokerages - Vimarsana News

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives $33.86 Average Price Target from Brokerages

Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Rating) have earned an average rating of “Moderate Buy” from the eight research firms that are covering the company, MarketBeat reports. One analyst has rated the stock with a sell recommendation and four have given a buy recommendation to the company. The average twelve-month price objective among […]